These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 441002)
1. [Effect of pharmacological treatment withdrawal on the blood pressure in hypertensive patients]. Markiewicz M; Florkiewicz H; Staśkiewicz J Pol Tyg Lek; 1979 Mar; 34(11):423-4. PubMed ID: 441002 [No Abstract] [Full Text] [Related]
2. Consequences of the discontinuation of antihypertensive treatment in successfully treated patients. Charalabopoulos K; Charalabopoulos A; Papalimneou V; Kiortsis D; Dimicco P; Kostoula OK; Karachalios GN Int J Clin Pract; 2005 Jun; 59(6):704-8. PubMed ID: 15924599 [TBL] [Abstract][Full Text] [Related]
3. Improved blood pressure control by monitoring compliance with antihypertensive therapy. Waeber B; Vetter W; Darioli R; Keller U; Brunner HR Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064 [TBL] [Abstract][Full Text] [Related]
4. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
5. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
7. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile]. Gorbunov VM; Savina LV; Metelitsa VI; Deev AD Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448 [TBL] [Abstract][Full Text] [Related]
8. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison. Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY; Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979 [TBL] [Abstract][Full Text] [Related]
9. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension. Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187 [TBL] [Abstract][Full Text] [Related]
10. Effects of prolonged administration of metolazone in the treatment of essential hypertension. Cangiano JL Curr Ther Res Clin Exp; 1976 Dec; 20(6):745-50. PubMed ID: 827420 [No Abstract] [Full Text] [Related]
11. Blood pressure characteristics of hypertensive patients in Austria as determined by self-monitoring (SCREEN-II). Hitzenberger G; Magometschnigg D Blood Press; 2003; 12(3):134-8. PubMed ID: 12875473 [TBL] [Abstract][Full Text] [Related]
12. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of hypertensive patients with adelphan-esidrex]. Shvedenko LA; Parashchak AP; Ryzhova VL Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666 [No Abstract] [Full Text] [Related]
14. [Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension]. Grajek S; Paradowski S; Kozłowska F; Gracz M Kardiol Pol; 1988; 31(8):515-22. PubMed ID: 3072437 [No Abstract] [Full Text] [Related]
15. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
16. Chronobiologic assessment of antihypertensive therapy. Tamura K; Kohno I; Tsuruta I; Ijiri H; Nakamura T Ann Ist Super Sanita; 1993; 29(4):693-704. PubMed ID: 7985930 [TBL] [Abstract][Full Text] [Related]
17. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension. Levine B Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450 [TBL] [Abstract][Full Text] [Related]
18. [Normalization of arterial pressure in all hypertensive patients: mission impossible?]. Waeber B Schweiz Med Wochenschr; 1998 Jan; 128(1-2):42-4. PubMed ID: 9491471 [No Abstract] [Full Text] [Related]
19. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994]. Poggi L; Chamontin B; Lang T; Menard J; Chevalier H; Gallois H; Cremier O Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382 [TBL] [Abstract][Full Text] [Related]